United States for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. They do not include

all information and notes required by generally accepted accounting principles for complete financial statements. However, except as disclosed herein, there has been no material change in the

information disclosed in the notes to the consolidated financial statements included in the Annual Report on Form 10-K of The Coca-Cola Company for the year ended

December 31, 2003. When used in these notes, the terms "Company," "we," "us" or "our" mean The Coca-Cola Company and all entities included in our financial statements. In the

opinion of management, all adjustments (including normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three month period ended

March 31, 2004 are not necessarily indicative of the results that may be expected for the year ending December 31, 2004.

Certain

amounts in our prior period financial statements and notes have been reclassified to conform to the current period presentation.

Refer

to Note B for a discussion of variable interest entities.

Note B Accounting Pronouncements

In December 2003, the Financial Accounting Standards Board ("FASB") issued FASB Interpretation No. 46 (revised December 2003)

("Interpretation 46"), "Consolidation of Variable Interest Entities."

Application of this interpretation was required in our financial statements for the year ended December 31, 2003 for interests in variable interest entities that are considered to be

special-purpose entities. Our Company determined that we do not have any arrangements or relationships with special-purpose entities. Application of Interpretation 46 for all other types of variable

interest entities was required for our Company effective March 31, 2004.

Interpretation

46 addresses the consolidation of business enterprises to which the usual condition (ownership of a majority voting interest) of consolidation does not apply. This

interpretation focuses on controlling financial interests that may be achieved through arrangements that do not involve voting interests. It concludes that in the absence of clear control through

voting interests, a company's exposure (variable interest) to the economic risks and potential rewards from the variable interest entity's assets and activities are the best evidence of control. If an

enterprise holds a majority of the variable interests of an entity, it would be considered the primary beneficiary. Upon consolidation, the primary beneficiary is generally required to include assets,

liabilities and noncontrolling interests at fair value and subsequently account for the variable interest as if it were consolidated based on majority voting interest.

In

our financial statements as of December 31, 2003 and prior to December 31, 2003, we consolidated all entities that we controlled by ownership of a majority of voting

interests. As a result of Interpretation 46, our balance sheet as of March 31, 2004 included the assets and liabilities of:

all

entities in which The Coca-Cola Company or its subsidiaries have ownership of a majority of voting interests; and additionally,

all

variable interest entities for which we are the primary beneficiary.

Our

Company holds interests in certain entities, primarily bottlers, previously accounted for under the equity method of accounting that are considered variable interest entities. These

variable interests relate to profit guarantees or subordinated financial support for these entities. Upon adoption of Interpretation 46 as of March 31, 2004, we consolidated assets of

approximately $383 million and liabilities of approximately $383 million that were previously not recorded on our balance sheet. We did not record a cumulative effect of an accounting

change, and prior periods were not restated. The results of operations of these variable interest entities will be included in our consolidated results beginning April 1, 2004 and are not

expected to have a material impact. Our Company's investment, plus any loans and guarantees, related to these variable interest entities total approximately $338 million, representing our

maximum exposure to loss. Any creditors of the variable interest entities

do not have recourse to the general credit of the Company as a result of including these variable interest entities in our financial statements.

Using

appropriate actuarial methods and assumptions, our Company accounts for defined benefit pension plans in accordance with Statement of Financial Accounting Standards ("SFAS")

No. 87, "Employers' Accounting for Pensions." We account for our nonpension postretirement benefits in accordance with SFAS No. 106, "Employers' Accounting for Postretirement Benefits

Other Than Pensions." In 2003, we adopted SFAS No. 132 (revised 2003), "Employers' Disclosures about Pensions and Other Postretirement Benefits," for all U.S. plans. As permitted by this

standard, we will adopt the annual disclosure provisions for all foreign plans for the year ending December 31, 2004. SFAS No. 132, as revised, requires additional disclosures in

year-end reports about assets, obligations, cash flows and net periodic benefit cost of defined benefit pension plans and other postretirement benefit plans. Refer to Note F for the

required disclosures in interim financial reports. This statement did not change the measurement or recognition of those plans required by SFAS No. 87, SFAS No. 88, "Employers'

Accounting for Settlements and Curtailments of Defined Benefit Pension Plans and for Termination Benefits," or SFAS No. 106.

The

FASB issued FASB Staff Position 106-1 ("FSP 106-1"), "Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and

Modernization Act of 2003," with an effective date for fiscal years ending after December 7, 2003. FSP 106-1 relates to the Medicare Prescription Drug, Improvement and Modernization

Act of 2003 (the "Act") signed into law on December 8, 2003. The Act introduced a prescription drug benefit under Medicare, as well as a federal subsidy to sponsors of retiree health care

benefit plans that provide a benefit that is at least actuarially equivalent to Medicare. We do not believe that we need to amend our postretirement health care plan in order to benefit from the

federal subsidy. As permitted by FSP 106-1, our Company made a one-time election to defer accounting for the effect of the Act until specific authoritative guidance is issued.

Therefore, in accordance with FSP 106-1, the net periodic postretirement benefit cost included in our financial statements and accompanying notes does not reflect the effects of the Act on

our plans. Specific authoritative guidance on the accounting for the federal subsidy is pending and that guidance, when issued, could require our Company to change previously reported information.

Note C Seasonality

Sales of nonalcoholic beverages are somewhat seasonal, with the second and third calendar quarters accounting for the highest sales volumes in the Northern

Hemisphere. The volume of sales in the beverages business may be affected by weather conditions.

Note D Comprehensive Income

The following table summarizes total comprehensive income for the applicable periods (in millions):

For the three months ended March 31,

2004

2003

Net income

$ 1,127

$ 835

Net foreign currency translation gain

400

267

Net gain on derivatives

Net change in unrealized gain (loss) on available-for-sale securities

13

(2

Net change in minimum pension liability

(39

(32

Total comprehensive income

$ 1,503

$ 1,071

Net

foreign currency translation gain for the three months ended March 31, 2004 resulted from the strength in most key currencies versus the U.S. dollar, especially a stronger

euro. Net foreign currency translation gain for the three months ended March 31, 2003 resulted primarily from the strengthening of certain currencies against the U.S. dollar, particularly the

euro and the Japanese yen.

Note E Commitments and Contingencies

On March 31, 2004, we were contingently liable for guarantees of indebtedness owed by third parties in the amount of $310 million. These guarantees

are related to third-party customers, bottlers and vendors and have arisen through the normal course of business. These guarantees have various terms, and none of these guarantees is individually

significant. The amount represents the maximum potential future payments we could be required to make under the guarantees; however, we do not consider it probable that we will be required to satisfy

these guarantees.

Additionally

in December 2003, we granted a $250 million stand-by line of credit to Coca-Cola FEMSA, S.A. de C.V. with normal market terms.

We

believe our exposure to concentrations of credit risk is limited due to the diverse geographic areas covered by our operations.

The

Company is also involved in various legal proceedings and tax matters. Management believes that any liability to the Company that may arise as a result of currently pending legal

proceedings and tax matters, including those discussed below, will not have a material adverse effect on the financial condition of the Company taken as a whole.

In

2003, the Securities and Exchange Commission began conducting an investigation into whether the Company or certain persons associated with our Company violated federal securities laws

in connection with the conduct alleged by a former employee of the Company. Additionally, in 2003 the United States Attorney's Office for the Northern District of Georgia commenced a criminal

investigation of the allegations raised by the same former employee. These investigations are ongoing, and to the Company's knowledge no criminal prosecutions or civil enforcement actions have been

filed. While the Company cannot predict whether any such actions will be filed in the future, the Company will continue to cooperate fully with the governmental investigations.

During

the period from 1970 to 1981, our Company owned Aqua-Chem, Inc. ("Aqua-Chem"). A division of Aqua-Chem manufactured certain boilers that

contained gaskets that Aqua-Chem purchased from outside suppliers. Several years after our Company sold this entity, Aqua-Chem received its first lawsuit relating to asbestos,

a component of some of the gaskets. Aqua-Chem has notified our Company that it believes we are obligated to them for certain costs and expenses associated with the litigation.

Aqua-Chem has demanded that our Company reimburse it for approximately $10 million for out-of-pocket litigation-related expenses incurred over the last

18 years and indemnify Aqua-Chem

against

any future liabilities and expenses for which there is no insurance. Our Company disputes Aqua-Chem's claims, and we believe we have no obligation to Aqua-Chem for any

of its past, present or future liabilities, costs or expenses. Furthermore, we believe we have substantial legal and factual defenses to Aqua-Chem's claims. The parties entered into

litigation to resolve this dispute, which is currently pending.

The

Company believes Aqua-Chem has substantial insurance coverage to pay Aqua-Chem's asbestos claimants. In connection with such insurance coverage, however, five

plaintiff insurance companies have filed an action against our Company, Aqua-Chem and sixteen insurance companies. Several of the policies that are the subject of this action were issued

to the Company during the period when our Company owned Aqua-Chem. The complaint seeks a determination of the respective rights and obligations under the insurance policies issued by the

insurance companies with regard to asbestos-related claims against Aqua-Chem. The five plaintiffs issued insurance policies with aggregate remaining limits of coverage of approximately

$145 million. The action also seeks a monetary judgment reimbursing any amounts paid by the plaintiffs in excess of their obligations. The Company believes that there are substantial legal and

factual arguments supporting the position that the insurance policies at issue provide coverage for the asbestos-related claims against Aqua-Chem, and the Company intends to assert these

arguments in response to the complaint.

An

estimate of possible losses, if any, related to the Aqua-Chem matters cannot be made at this time.

The

Competition Directorate of the European Commission is conducting an investigation of various commercial and market practices of the Company and bottlers in Austria, Belgium, Denmark,

Germany and Great Britain. The Commission may, following its usual practice, issue one or more statements of objection, after which the Company and the bottlers would have formal rights to reply and

to judicial appeal in the event of an adverse decision by the Commission. The Commission has authority to impose fines in connection with an adverse decision; however, the Company is not able to

predict whether fines would be imposed or the amount of such fines.

In

2000, the Spanish competition service commenced an investigation of our Company and certain bottlers in Spain. In December 2003, the Spanish competition service suspended its

investigation pending notice from the European Commission as to how the European Commission will proceed in its aforementioned investigation.

The

French competition directorate has also initiated an inquiry into commercial practices related to the soft drinks sector in France; however, no conclusions have been communicated to

the Company by the directorate.

At

the time of divesting our interest in a consolidated entity, we sometimes agree to indemnify the buyer for specific liabilities related to the period we owned the entity. Management

believes that any liability to the Company that may arise as a result of any such indemnification agreements will not have a material adverse effect on the financial condition of the Company taken as

a whole.

10

NOTE F Pension and Other Postretirement Benefit Plans

Net periodic benefit cost for our pension and other postretirement benefit plans for the three months ended March 31, 2004 and 2003 consists of the

following (in millions):

Pension Benefits

Other Benefits

2004

2003

2004

2003

Service cost

$ 21

$ 18

$ 8

$ 6

Interest cost

37

35

12

11

Expected return on plan assets

(38

(32

Amortization of prior service cost

Recognized net actuarial loss

Net periodic benefit cost

$ 30

$ 28

$ 22

$ 18

We

contributed $100 million to the primary qualified U.S. pension plan in January 2004, and we anticipate contributing up to an additional $39 million to this plan

later in 2004. We expect to contribute up to $46 million to the U.S. postretirement benefit plan during 2004.

Note G Significant Operating Item

In the first quarter of 2003, the Company reached a settlement with certain defendants in a vitamin antitrust litigation matter. In that litigation, the Company

alleged that certain vitamin manufacturers participated in a global conspiracy to fix the price of some vitamins, including vitamins used in the manufacture of some of the Company's products. During

the first quarter of 2003, the Company received a settlement relating to this litigation of approximately $52 million on a pretax basis, or $0.01 per share on an after-tax basis.

The amount was recorded as a reduction to cost of goods sold.

Note H Streamlining Costs

During 2003, the Company took steps to streamline and simplify its operations, primarily in North America and Germany. In North America, the Company integrated

the operations of three formerly separate North American business units Coca-Cola North America, Minute Maid and Fountain. Our Company-owned bottler in Germany,

Coca-Cola Erfrischungsgetraenke AG ("CCEAG"), took steps to improve its efficiency in sales, distribution and manufacturing, and our German Division office also implemented streamlining

initiatives. Selected other operations also took steps to streamline their operations to improve overall efficiency and effectiveness. In accordance with SFAS No. 146, "Accounting for Costs

Associated with Exit or Disposal Activities," a liability is accrued only when certain criteria are met. All of the Company's streamlining initiatives met these criteria as of December 31,

2003, and all related costs were incurred on or before December 31, 2003.

Employees

separated from the Company as a result of these streamlining initiatives were offered severance or early retirement packages, as appropriate, that included both financial and

nonfinancial components. The expenses recorded for the three months ended March 31, 2003 and for the year ended December 31, 2003 included costs associated with involuntary terminations

and other direct costs associated with implementing these initiatives. As of December 31, 2003, approximately 3,700 associates had been separated pursuant to these streamlining initiatives.

Other direct costs included the relocation of employees; contract termination costs; costs associated with the development, communication and administration of these initiatives; and asset

write-offs. During 2003, the Company incurred total pretax expenses related to these streamlining initiatives of approximately $561 million, or $0.15 per share after tax. In the

first quarter of 2003, the Company incurred total pretax expenses related to these

11

streamlining

initiatives of approximately $159 million, or $0.04 per share after tax. These expenses were recorded in the line item other operating charges.

The

table below summarizes the balance of accrued streamlining expenses and the movement in that accrual as of and for the three months ended March 31, 2004 (in millions):

Cost Summary

Accrued

Balance

December 31,

2003

Payments

Noncash

and

Exchange

Accrued

Balance

March 31,

2004

Severance pay and benefits

$ 138

$ (55

$ 2

$ 85

Retirement related benefits

29

(7

22

Outside services legal,

outplacement, consulting

11

(10

Other direct costs

51

(11

40

Total

$ 229

$ (76

$ (5

$ 148

1 As of March 31, 2004 and December 31, 2003, $125 million and $206 million, respectively, were included in the balance sheet line item accounts payable and accrued expenses. As of March 31, 2004 and

December 31, 2003, $23 million was included in the balance sheet line item other liabilities.

Note I Acquisition

In March 2003, our Company acquired a 100 percent ownership interest in Truesdale Packaging Company LLC (Truesdale) from Coca-Cola

Enterprises Inc. for cash consideration of approximately $58 million. Truesdale owns a noncarbonated beverage production facility. The purchase price was primarily allocated to the

property, plant and equipment acquired. No amount was allocated to intangible assets. Truesdale is included in our North America operating segment.

Note J Operating Segments

Our Company's operating structure includes the following operating segments: North America; Africa; Asia; Europe, Eurasia and Middle East; Latin America; and

Corporate. North America includes the United States, Canada and Puerto Rico.

12

Information

about our Company's operations as of and for the three months ended March 31, 2004 and 2003, by operating segment, is as follows (in millions):

North

America

Africa

Asia

Europe

Eurasia &

Middle East

Latin

America

Corporate

Consolidated

2004

Net operating revenues

$ 1,594

$ 229

$ 1,022

$ 1,672

$ 513

$ 48

$ 5,078

Operating income

375

82

413

564

262

(245

1,451

Income before income

taxes

376

82

433

557

293

(229

1,512

Identifiable operating

assets

5,021

712

2,118

5,602

1,377

8,662

23,492

Investments

107

133

1,348

1,269

1,404

1,414

5,675

2003

Net operating revenues

$ 1,426

$ 175

$ 1,086

$ 1,303

$ 483

$ 29

$ 4,502

Operating income (1)

254

67

348

348

242

(183

1,076

Income before income

taxes (1)

270

64

360

329

269

(169

1,123

Identifiable operating

assets

5,270

585

2,587

4,860

1,214

6,755

21,271

Investments

102

109

1,180

1,230

1,322

1,005

4,948

Intercompany

transfers between operating segments are not material.

(1)Operating

income and income before income taxes were reduced by $81 million for North America, $55 million for Europe, Eurasia and Middle East, and $23 million

for Corporate as a result of other operating charges associated with streamlining initiatives. Refer to Note H. Operating income and income before income taxes were increased by

$52 million for Corporate as a result of the Company's receipt of a settlement related to a vitamin antitrust litigation matter. Refer to Note G.

13

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

RESULTS OF OPERATIONS

As a result of our Company's normal quarterly closing calendar, a shift in the number of shipping days occurred between the first quarter and the fourth quarter

of 2004, when compared to the prior year periods. The four additional shipping days in the first quarter of 2004 compared to the first quarter of 2003 had the effect of increasing our first quarter

2004 net operating revenues and expenses compared to the first quarter of 2003, and provided a slight benefit to first quarter 2004 earnings per share. Correspondingly, our fourth quarter of 2004 will

have three fewer shipping days compared to the fourth quarter of 2003.

Net Operating Revenues

Net operating revenues were $5,078 million in the first quarter of 2004, compared to $4,502 million in the first quarter of 2003, an increase of

$576 million or 13 percent.

The

following table indicates, on a percentage basis, the estimated impact of key factors resulting in significant increases (decreases) in net operating revenues:

Three Months Ended March 31,

2004 vs. 2003

Increase in gallon sales, including acquisitions

Structural changes

(5

Price and product/geographic mix

Impact of currency fluctuations versus the U.S. dollar

Total percentage increase

13

The

increase in gallon sales was partially attributable to the four additional shipping days in the first quarter of 2004 as compared to the first quarter of 2003. Refer to the

discussion above.

Structural

changes decreased our first quarter 2004 net operating revenues by 5 percent compared to the first quarter of 2003. Effective October 1, 2003, the Company and

all of our bottling partners in Japan created a nationally integrated supply chain management company to centralize procurement, production and logistics operations for the entire

Coca-Cola system in Japan. As a result, a portion of our Company's business has essentially been converted from a finished product business model to a concentrate business model. This

shift of certain products to a concentrate business model resulted in a reduction of revenues and costs of goods sold, each in the amount of approximately $220 million, for the three months

ended March 31, 2004 compared to the three months ended March 31, 2003. This change will continue to affect the comparison of certain line items of the Company's statements of income

over the next two quarters but will not impact the Company's underlying operating income. We also deconsolidated the Cosmos Bottling Corporation ("CBC") during the second quarter of 2003. CBC is an

established carbonated soft-drink business in the Philippines and was included in our Asia operating segment. The three months ended March 31, 2003 included the net operating

revenues of CBC, whereas 2004 does not include net operating revenues for CBC.

We

improved pricing of concentrate in several key countries in the first quarter of 2004. The price and product/geographic mix increase was positively impacted by improved overall

package mix and selected pricing initiatives by our consolidated bottler in Germany, Coca-Cola Erfrischungsgetraenke AG ("CCEAG"). On January 1, 2003, the German government enacted

a deposit law on certain nonreturnable beverage packages. This change in law and subsequent developments resulted in most retailers delisting nonreturnable packages. This change created a difficult

operating environment during 2003; however, management has successfully positioned our Company to respond to German consumers' increasing preference for returnable packaging.

14

The

impact of currency fluctuations resulted from the strength of most key currencies versus the U.S. dollar, especially a stronger euro that favorably impacted the Europe, Eurasia and

Middle East operating segment and a stronger Japanese yen that favorably impacted our Asia operating segment. Refer to heading "Exchange."

The

contribution to net operating revenues from Company operations is as follows (in millions):

Three months ended March 31,

2004

2003

Company operations, excluding bottling operations

$ 4,393

$ 3,922

Company-owned bottling operations

685

580

Consolidated net operating revenues

$ 5,078

$ 4,502

Gross Profit

Our gross profit margin increased to 65.5 percent in the first quarter of 2004 from 64.1 percent in the first quarter of 2003. The creation of the

nationally integrated supply chain company in Japan and the deconsolidation of CBC (each previously discussed under the heading "Net Operating Revenues") improved the 2004 gross margin compared to

2003. Generally, bottling and finished product operations, such as our Japan tea business that was integrated into the supply chain company and CBC, produce higher net operating revenues but lower

gross profit margins compared to concentrate and syrup operations. Our receipt during the first quarter of 2003 of a settlement of approximately $52 million from certain defendants in a vitamin

antitrust litigation positively impacted our 2003 gross profit. This amount was recorded as a reduction to cost of goods sold and impacted the Corporate operating segment. Refer to Note G.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased $224 million or 14 percent for the first quarter of 2004, as compared to the first quarter of

2003. Approximately 6 percentage points of this increase were due to an overall weaker U.S. dollar (especially compared to the euro and the Japanese yen). Increased selling expenses were

largely responsible for the remaining increase due to increased investments in marketing activities and the additional shipping days in the first quarter of 2004.

Other Operating Charges

In the first quarter of 2003, the Company recorded charges of approximately $159 million, or $0.04 per share after tax, related to streamlining

initiatives, primarily in North America and Germany. Of these charges, approximately $81 million impacted the North America operating segment, approximately $55 million impacted the

Europe, Eurasia and Middle East operating segment, and approximately $23 million impacted the Corporate operating segment. Approximately 900 associates had been separated as of March 31,

2003. Refer to Note H.

Operating Income and Operating Margin

Operating income was $1,451 million in the first quarter of 2004, compared to $1,076 million in the first quarter of 2003, an increase of

$375 million or 35 percent. Our operating margin for the first quarter of 2004 was 28.6 percent, compared to 23.9 percent for the comparable period in 2003. Operating

income and operating margin reflected solid results from the Company's geographic operating segments; the

positive impact of currency; the streamlining initiatives and vitamin litigation settlement that occurred in the first quarter of 2003; and the impact of the other items discussed above.

Currencies

positively impacted operating income in the first quarter of 2004 by approximately 13 percent versus the comparable prior year period as a result of the strength of

most key currencies

15

versus

the U.S. dollar, especially a stronger euro and a stronger Japanese yen. We calculated this 13 percent positive impact based on reported results, including the impact that the

streamlining initiatives and the vitamin litigation settlement had on first quarter 2003 results. Refer to heading "Exchange."

The

creation of the supply chain management company in Japan and the deconsolidation of CBC improved our first quarter 2004 operating margin compared to our first quarter 2003 operating

margin, for the reasons explained under the heading "Gross Profit."

Interest Income

Interest income decreased to $35 million for the first quarter of 2004 from $56 million for the first quarter of 2003. This decrease was primarily

due to lower interest rates in 2004 earned on short-term investments and interest on 2003 tax receivables. Nevertheless, the Company continues to benefit from cash invested in locations

outside the United States earning higher interest rates than could be obtained within the United States.

Equity Income Net

Our Company's share of income from equity method investments for the first quarter of 2004 totaled $95 million, compared to $49 million in the first

quarter of 2003, an increase of $46 million or 94 percent. Equity income in all geographic regions improved for the three months ended March 31, 2004 versus the comparable 2003

period. For the 2004 period versus the 2003 period, our equity income benefited from favorable pricing at key bottling operations and from the positive impact of the strength of most key currencies

versus the U.S. dollar, especially a stronger euro and a stronger Japanese yen.

Other Income (Loss) Net

Other income (loss) net was a net loss of $25 million for the first quarter of 2004 compared to a net loss of $13 million for

the first quarter of 2003, a difference of $12 million. This line item included the impact of foreign exchange losses, accretion of the discounted value of the CCEAG liability and minority

interests. Comparing the first quarter of 2003 to the first quarter of 2004, no significant changes occurred for these items.

Income Taxes

Our effective tax rate was 25.5 percent for the first quarter of 2004 compared to 25.6 percent for the first quarter of 2003.

This

first quarter of 2004 effective tax rate is in line with our previously disclosed expectations. This effective tax rate reflects tax benefits derived from significant operations

outside the United States that are taxed at rates lower than the U.S. statutory rate of 35 percent.

The

25.6 percent effective tax rate for the first quarter of 2003 included the following:

The

effective tax rate for the costs related to the streamlining initiatives was approximately 35 percent.

The

effective tax rate for the proceeds received related to the vitamin antitrust litigation matter was approximately 35 percent.

The

effective tax rate for all other pretax income was approximately 26.5 percent.

For

the full year of 2004 and for the foreseeable future, based on current tax laws, the Company's effective tax rate on operations is expected to be approximately 25.5 percent.

16

Beverage Volume

We measure our sales volume in two ways: (1) gallons and (2) unit cases of finished products. "Gallons" is a unit of measurement for concentrates,

syrups, beverage bases, finished beverages and powders (in all cases, expressed in equivalent gallons of syrup) for all beverage products which are reportable as unit case volume. Most of our revenues

are based on gallon sales. Gallon sales and unit case volume are not necessarily equal during any given period. Items such as seasonality, bottlers' inventory practices, extra shipping

days/consumption days, supply point changes, timing of price increases and new product introductions can create differences between gallon sales and unit case volume.

Although

most of our Company's revenues are not based directly on unit case volume, we believe unit case volume is one of the measures of the underlying strength of the

Coca-Cola system because it measures trends at the consumer level. Comparing first quarter 2004 unit case volume to volume for the first quarter of 2003, approximate unit case volume

growth results are as follows:

Unit Case Volume

Growth Based on

Average Daily Sales

2004 versus 2003

Percentage Change

Reported Unit Case

Volume Growth

2004 versus 2003

Percentage Change

Worldwide

North America operations

International operations total

Africa

(1

Asia

Europe, Eurasia & Middle East

12

Latin America

Unit

case volume growth based on average daily sales is computed by comparing the average daily sales in each of the corresponding periods. Average daily sales for each quarter are the

actual unit cases shipped during the quarter divided by the number of days in the quarter.

Reported

unit case volume growth is computed by comparing the actual unit cases shipped in the first quarter of 2004 to the actual unit cases shipped in the first quarter of 2003. In the

current period, these amounts are greater than the amounts computed on an average daily sales basis because of extra consumption days in the first quarter of 2004 as compared to the first quarter of

2003. The difference in consumption days will be largely offset in the fourth quarter of 2004.

17

FINANCIAL CONDITION

Net Cash Flow Provided by Operating Activities

Net cash provided by operating activities in the first three months of 2004 amounted to $1,160 million versus $599 million for the comparable period

in 2003, an increase of $561 million. Net income of $1,127 million for the first quarter of 2004 compared to net income of $835 million for the comparable quarter of 2003, as well

as efficient management of working capital in 2004, contributed to this increased cash flow.

Investing Activities

Net cash used in investing activities totaled $219 million for the first three months of 2004, compared to $185 million for the comparable period in

2003, an increase of $34 million. During the first three months of 2004, cash outlays for investing activities included purchases of property, plant and equipment of $170 million. Our

Company currently estimates that purchases of property, plant and equipment in 2004 will be less than $1 billion.

During

the first three months of 2003, cash outlays for investing activities included purchases of property, plant and equipment of $195 million and the acquisition of Truesdale

Packaging Company LLC from Coca-Cola Enterprises Inc. for approximately $58 million (refer to Note I).

Financing Activities

Our financing activities include net borrowings, dividend payments, share issuances and share repurchases. Net cash used in financing activities totaled

$63 million for the first three months of 2004 compared to net cash provided by financing activities of $385 million for the first three months of 2003.

In

the first three months of 2004, the Company had issuances of debt of $1,466 million and payments of debt of $485 million. The issuances of debt primarily included

$754 million of issuances of commercial paper with maturities of 90 days or less and $631 million in issuances of commercial paper with maturities of more than 90 days. The

payments of debt included $145 million related to commercial paper with maturities of more than 90 days. Furthermore, in the first quarter of 2004, we settled $322 million of

current maturities of long-term debt. In the first three months of 2003, the Company had issuances of debt of $1,026 million and payments of debt of $311 million. The

issuances of debt primarily included $711 million of issuances of commercial paper with maturities of 90 days or less and $271 million in issuances of commercial paper with

maturities of greater than 90 days. The payments of debt primarily included $299 million related to commercial paper with maturities of greater than 90 days.

During

the first three months of 2004 and 2003, the Company repurchased common stock under the stock repurchase plan authorized by our Board of Directors in October 1996. During

the first three months of 2004, the Company repurchased approximately 9.9 million shares of common stock at an average cost of $49.31 per share under the 1996 plan. During the first three

months of 2003, the Company repurchased approximately 8.3 million shares of common stock at an average cost of $38.48 per share under the 1996 plan. The cost to purchase these shares of common

stock for treasury was $486 million for the first three months of 2004 compared to $319 million for the first three months of 2003. As strong cash flows are expected to continue in the

future, the Company currently expects its 2004 share repurchase levels to be at least $2 billion, including the first quarter purchases described above.

For

the quarter ended March 31, 2004, our Company paid dividends of $602 million. As of March 31, 2003, dividends of approximately $545 million were accrued

but were not paid until the beginning of the second quarter of 2003.

18

Financial Position

Our balance sheet as of March 31, 2004, as compared to our balance sheet as of December 31, 2003, was impacted by the following:

The

increase in cash and cash equivalents of $932 million was due primarily to net cash provided by operating activities of $1,160 million in the first quarter

of 2004.

The

increase in loans and notes payable of $1,246 million was due to the issuance of commercial paper during the first quarter of 2004 to meet short-term

cash needs, including the quarterly dividend payment and repurchases of common stock.

The

overall increase in total assets as of March 31, 2004, compared to December 31, 2003, was primarily related to the increase in cash and cash equivalents mentioned

above, which impacted the Corporate operating segment; the impact of the strength in most key currencies versus the U.S. dollar, especially a stronger euro (that impacted our Europe, Eurasia and

Middle East operating segment) and a stronger Japanese yen (that impacted our Asia operating segment); and the consolidation of certain entities in accordance with FASB Interpretation No. 46.

Refer to Note B. The consolidation of such entities specifically accounted for an increase of approximately $270 million to our property, plant and equipment.

Exchange

Our international operations are subject to certain opportunities and risks, including currency fluctuations and government actions. We closely monitor our

operations in each country and seek to adopt appropriate strategies that are responsive to changing economic and political environments and to fluctuations in foreign currencies.

We

use approximately 50 functional currencies. Due to our global operations, weaknesses in some of these currencies are often offset by strengths in others. Our foreign currency

management program is designed to mitigate, over time, a portion of the impact of exchange on net income and earnings per share. Taking into account the effects of our hedging activities, the impact

of a weaker U.S. dollar increased our reported operating income by approximately 13 percent in the first quarter of 2004 compared to the first quarter of 2003. We calculated this

13 percent positive impact based on reported results, including the impact that the streamlining initiatives and the vitamin litigation settlement had

on first quarter 2003 results. For the remainder of 2004, the Company expects exchange to have a positive but less significant impact on our operating results.

The

Company will continue to manage its foreign currency exposures to mitigate over time a portion of the impact of exchange on net income and earnings per share. Our Company conducts

business in more than 200 countries around the world, and we manage foreign currency exposures through the portfolio effect of the basket of functional currencies in which we do business.

19

FORWARD-LOOKING STATEMENTS

Certain written and oral statements made by our Company and subsidiaries or with the approval of an authorized executive officer of our Company may constitute

"forward-looking statements" as defined under the Private Securities Litigation Reform Act of 1995, including statements made in this report and other filings with the Securities and Exchange

Commission. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will" and similar expressions identify forward-looking statements, which generally are not

historical in nature. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future including statements relating

to volume growth, share of sales and earnings per share growth and statements expressing general optimism about future operating results are forward-looking statements.

Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our Company's historical experience and our present expectations or

projections. As and when made, management believes that these forward-looking statements are reasonable. However, caution should be taken not to place undue reliance on any such forward-looking

statements since such statements speak only as of the date when made. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new

information, future events or otherwise.

The

following are some of the factors that could cause our Company's actual results to differ materially from the expected results described in or underlying our Company's

forward-looking statements:

Economic

and political conditions, especially in international markets, including civil unrest, product boycotts, governmental changes and restrictions on the ability to

transfer capital across borders. Without limiting the preceding sentence, the current unstable economic and political conditions and civil unrest in the Middle East, North Korea or elsewhere, the

unstable situation in Iraq, or the continuation or escalation of terrorism, could have adverse impacts on our Company's business results or financial condition.

Changes

in the nonalcoholic beverages business environment. These include, without limitation, changes in consumer preferences, including changes based on health or

nutrition considerations; competitive product and pricing pressures; and our ability to gain or maintain share of sales in the global market as a result of actions by competitors. Factors such as

these could impact our earnings, share of sales and volume growth.

Foreign

currency rate fluctuations, interest rate fluctuations and other capital market conditions. Most of our exposures to capital markets, including foreign currency and

interest rates, are managed on a consolidated basis, which allows us to net certain exposures and, thus, take advantage of any natural offsets. We use derivative financial instruments to reduce our

net exposure to financial risks. There can be no assurance, however, that our financial risk management program will be successful in reducing capital market exposures.

Adverse

weather conditions, which could reduce demand for Company products.

The

effectiveness of our advertising, marketing and promotional programs.

Fluctuations

in the cost and availability of raw materials, the cost of energy, transportation and other necessary services; our ability to maintain favorable supplier

arrangements and relationships; our ability to avoid product recalls; and our ability to avoid disruptions in production output caused by events such as natural disasters, power outages, labor

strikes, or the like.

20

Our

ability to achieve earnings goals, which are generated based on projected volumes and sales of many product types, some of which are more profitable than others. There

can be no assurance that we will achieve the projected level or mix of product sales.

Our

ability to effectively align ourselves with our bottling system as we focus on increasing the investment in our brands; seeking efficiencies throughout the supply chain;

delivering more value for our customers; and better meeting the needs of our consumers.

Changes

in laws and regulations, including changes in accounting standards, taxation requirements (including tax rate changes, new tax laws and revised tax law

interpretations), laws concerning food and beverages, competition laws, employment laws and environmental laws in domestic or foreign jurisdictions.

Our

ability to penetrate developing and emerging markets, which also depends on economic and political conditions, and how well we are able to acquire or form strategic

business alliances with local bottlers and make necessary infrastructure enhancements to production facilities, distribution networks, sales equipment and technology. Moreover, the supply of products

in developing markets must match the customers' demand for those products, and due to product price and cultural differences, there can be no assurance of product acceptance in any particular market.

The

uncertainties of litigation, as well as other risks and uncertainties detailed from time to time in our Company's Securities and Exchange Commission filings.

The

foregoing list of important factors is not exclusive.

21

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We have no material changes to the disclosure on this matter made in our Annual Report on Form 10-K for the year ended December 31,

2003.

Item 4. Controls and Procedures

The Company, under the supervision and with the participation of its management, including the Chief Executive Officer and the Chief Financial Officer, evaluated

the effectiveness of the design and operation of the Company's "disclosure controls and procedures" (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the

"Exchange Act")) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company's disclosure

controls and procedures are effective in timely making known to them material information relating to the Company and the Company's consolidated subsidiaries required to be disclosed in the Company's

reports filed or submitted under the Exchange Act. There has been no change in the Company's internal control over

financial reporting during the quarter ended March 31, 2004 that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

22

Part II. Other Information

Item 1. Legal Proceedings

On March 26, 2004, five plaintiff insurance companies filed an action (Century Indemnity Company, et al. v.

Aqua-Chem, Inc., The Coca-Cola Company, et al., Case No. 04CV002852) in the Circuit Court of Milwaukee County, Wisconsin against our

Company, Aqua-Chem, Inc. and sixteen insurance companies. Several of the policies that are the subject of this action were issued to the Company during the period (1970 to 1981)

when our Company owned Aqua-Chem. The complaint seeks a determination of the respective rights and obligations under the insurance policies issued by the insurance companies with regard to

asbestos-related claims against Aqua-Chem. The five plaintiffs issued insurance policies with aggregate remaining limits of coverage of approximately $145 million. The action also

seeks a monetary judgment reimbursing any amounts paid by the plaintiffs in excess of their obligations. The Company believes that there are substantial legal and factual arguments supporting the

position that the insurance policies at issue provide coverage for the asbestos-related claims against Aqua-Chem, and the Company intends to assert these arguments in response to the

complaint.

Item 2. Changes in Securities, Use of Proceeds and Issuer Purchases of Equity Securities

The following table presents information with respect to purchases of common stock of the Company made during the three months ended March 31, 2004 by The

Coca-Cola Company or any "affiliated purchaser" of The Coca-Cola Company, as defined in Rule 10b-18(a)(3) under the Exchange Act.

Period

(a)

Total Number

of Shares

Purchased

(b)

Average

Price Paid

Per Share

(c)

Total Number of

Shares Purchased as Part of Publicly

Announced Plans or Programs

(d)

Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs

January 1, 2004 through January 31, 2004

308,432

$ 50.39

300,000

146,391,140

February 1, 2004 through February 29, 2004

1,695,951

$ 49.68

1,400,000

144,991,140

March 1, 2004 through March 31, 2004

8,285,003

$ 49.14

8,150,000

136,841,140

Total

10,289,386

$ 49.26

9,850,000

136,841,140

1 The

total number of shares purchased includes: (i) shares purchased pursuant to the 1996 Plan described in footnote (2) below; and (ii) shares

purchased in connection with stock swaps, employee payroll withholding and cancellation of restricted stock totaling 8,432 shares, 295,951 shares and 135,003 shares, respectively, for the months of

January, February and March, 2004.

2 On

October 17, 1996, we publicly announced that our Board of Directors had authorized a plan (the "1996 Plan") for the Company to purchase up to 206 million

shares of our Company's common stock prior to October 31, 2006. This was in addition to approximately 44 million shares, previously authorized for purchase prior to December 31,

2000, that had not been purchased by the Company as of October 16, 1996 but that were purchased by the Company prior to the commencement of purchases under the 1996 plan in 1998. This column

discloses the number of shares purchased pursuant to the 1996 Plan during the indicated time periods.

23

Item 4. Submission of Matters to a Vote of Security Holders

The Company's Annual Meeting of Share Owners was held on Wednesday, April 21, 2004, in Wilmington, Delaware, at which the following matters were submitted

to a vote of the share owners:

(a)Votes

regarding the election of the persons named below as Directors for a term expiring in 2005 were as follows:

FOR

WITHHELD

Herbert A. Allen

1,996,923,877

78,069,147

Ronald W. Allen

2,001,902,021

73,091,003

Cathleen P. Black

1,993,946,970

81,046,054

Warren E. Buffett

1,740,492,681

334,500,343

Douglas N. Daft

2,020,042,244

54,950,780

Barry Diller

2,028,723,022

46,270,002

Donald R. Keough

2,014,967,425

60,025,599

Susan Bennett King

2,022,603,062

52,389,962

Maria Elena Lagomasino

2,029,211,798

45,781,226

Donald F. McHenry

2,020,455,848

54,537,176

Robert L. Nardelli

1,999,644,175

75,348,849

Sam Nunn

2,014,684,501

60,308,523

J. Pedro Reinhard

1,999,115,726

75,877,298

James D. Robinson III

2,020,141,809

54,851,215

Peter V. Ueberroth

1,991,807,185

83,185,839

James B. Williams

2,010,119,825

64,873,199

(b)Votes

regarding ratification of the appointment of Ernst & Young LLP as independent auditors of the Company to serve for the fiscal year ending December 31, 2004 were as

follows:

FOR

AGAINST

ABSTENTIONS

BROKER

NON-VOTES

1,998,476,927

59,028,128

17,487,969

(c)Votes

on a share-owner proposal regarding a report related to global HIV/AIDS pandemic were as follows:

FOR

AGAINST

ABSTENTIONS

BROKER

NON-VOTES

1,990,402,467

42,045,735

42,544,822

(d)Votes

on a share-owner proposal regarding a stock option glass ceiling report were as follows:

FOR

AGAINST

ABSTENTIONS

BROKER

NON-VOTES

86,246,281

1,555,608,140

99,128,087

334,010,516

(e)Votes

on a share-owner proposal regarding restricted stock were as follows:

FOR

AGAINST

ABSTENTIONS

BROKER

NON-VOTES

475,585,792

1,237,331,002

28,065,714

334,010,516

24

(f)Votes

on a share-owner proposal regarding senior executive participation in the Company's Compensation & Deferral Investment Program were as follows:

FOR

AGAINST

ABSTENTIONS

BROKER

NON-VOTES

153,434,488

1,550,826,161

36,721,859

334,010,516

(g)Votes

on a share-owner proposal regarding China business principles were as follows:

FOR

AGAINST

ABSTENTIONS

BROKER

NON-VOTES

97,313,804

1,520,168,516

123,500,188

334,010,516

(h)Votes

on a share-owner proposal regarding separate positions of CEO and Chairman were as follows:

FOR

AGAINST

ABSTENTIONS

BROKER

NON-VOTES

423,860,249

1,288,869,483

28,252,776